[{"address1": "500 West 5th Street", "address2": "Suite 1200", "city": "Austin", "state": "TX", "zip": "78701", "country": "United States", "phone": "512 900 4690", "website": "https://www.shattucklabs.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.", "fullTimeEmployees": 75, "companyOfficers": [{"maxAge": 1, "name": "Dr. Taylor H. Schreiber M.D., Ph.D.", "age": 43, "title": "Co-Founder, CEO & Director", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 792885, "exercisedValue": 0, "unexercisedValue": 357187}, {"maxAge": 1, "name": "Mr. Andrew R. Neill M.B.A.", "age": 37, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2023, "totalPay": 603956, "exercisedValue": 0, "unexercisedValue": 496087}, {"maxAge": 1, "name": "Dr. Arunthathy Nirmalini Pandite M.B.A., M.D.", "age": 64, "title": "Chief Medical Officer", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 695243, "exercisedValue": 0, "unexercisedValue": 434807}, {"maxAge": 1, "name": "Dr. Abhinav A. Shukla Ph.D.", "age": 50, "title": "Chief Technical Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 567398, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Conor  Richardson CPA", "title": "Vice President of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Stout J.D., Ph.D.", "age": 48, "title": "General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Casi  DeYoung", "age": 52, "title": "Chief Business Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 523482, "exercisedValue": 0, "unexercisedValue": 493071}, {"maxAge": 1, "name": "Dr. Thomas  Lampkin Pharm.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. George  Fromm Ph.D.", "title": "Chief Scientific Officer of ARC Platform", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Suresh de Silva Ph.D.", "title": "Chief Scientific Officer of GADLEN Platform", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1717200000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 7.26, "open": 7.2, "dayLow": 7.02, "dayHigh": 7.45, "regularMarketPreviousClose": 7.26, "regularMarketOpen": 7.2, "regularMarketDayLow": 7.02, "regularMarketDayHigh": 7.45, "beta": 1.861, "forwardPE": -4.280488, "volume": 118705, "regularMarketVolume": 118705, "averageVolume": 313169, "averageVolume10days": 162090, "averageDailyVolume10Day": 162090, "bid": 7.0, "ask": 7.08, "bidSize": 200, "askSize": 200, "marketCap": 333807328, "fiftyTwoWeekLow": 1.33, "fiftyTwoWeekHigh": 11.76, "priceToSalesTrailing12Months": 122.949295, "fiftyDayAverage": 9.0199, "twoHundredDayAverage": 6.127285, "currency": "USD", "enterpriseValue": 223188128, "floatShares": 31888090, "sharesOutstanding": 47550900, "sharesShort": 1583371, "sharesShortPriorMonth": 1797371, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.033299997, "heldPercentInsiders": 0.13332, "heldPercentInstitutions": 0.64111, "shortRatio": 4.19, "shortPercentOfFloat": 0.050100002, "impliedSharesOutstanding": 47550900, "bookValue": 2.711, "priceToBook": 2.5894504, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -85078000, "trailingEps": -1.93, "forwardEps": -1.64, "enterpriseToRevenue": 82.206, "enterpriseToEbitda": -2.594, "52WeekChange": 1.4631579, "SandP52WeekChange": 0.23232913, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "STTK", "underlyingSymbol": "STTK", "shortName": "Shattuck Labs, Inc.", "longName": "Shattuck Labs, Inc.", "firstTradeDateEpochUtc": 1602250200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "64a83d67-d0cd-3885-8206-d0f94edae33a", "messageBoardId": "finmb_378179277", "gmtOffSetMilliseconds": -14400000, "currentPrice": 7.02, "targetHighPrice": 28.0, "targetLowPrice": 10.0, "targetMeanPrice": 15.5, "targetMedianPrice": 12.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 114633000, "totalCashPerShare": 2.411, "ebitda": -86038000, "totalDebt": 4014000, "quickRatio": 8.0, "currentRatio": 9.148, "totalRevenue": 2715000, "debtToEquity": 3.116, "revenuePerShare": 0.061, "returnOnAssets": -0.34736001, "returnOnEquity": -0.59398, "freeCashflow": -41475000, "operatingCashflow": -70928000, "revenueGrowth": 18.561, "operatingMargins": -17.976679, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-10"}]